Beijing Innocare Pharma Tech
Clinical trials sponsored by Beijing Innocare Pharma Tech, explained in plain language.
A Chinese pharmaceutical company developing and commercializing drugs.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New drug ICP-538 tested in healthy people for first time Results expected Sep 2026 (estimated)
- New pill could ease severe psoriasis in just 12 weeks Results expected Oct 2026 (estimated)
- New pill could tame tough eczema without creams Results expected Nov 2026 (estimated)
- New pill could stop the maddening itch of prurigo nodularis Results expected Mar 2027 (estimated)
- New pill could tame skin lupus flares Results expected Mar 2027 (estimated)
-
Can a Two-Drug combo outsmart a tough blood cancer?
Disease control Not yet recruitingThis phase 3 trial is testing whether combining two oral drugs—ICP-248 and orelabrutinib—works better than the current drug pirtobrutinib alone for people with mantle cell lymphoma that has returned or stopped responding to treatment. About 280 participants will be randomly assig…
Phase 3 • Sponsor: Beijing InnoCare Pharma Tech Co., Ltd. • Aim: Disease control
Last updated Aug 27, 2026 00:00 UTC
-
Can a pill tame Sjögren's? a new drug puts the immune system to the test
Disease control Not yet recruitingThis phase 2 trial is testing whether an oral drug called ICP-488 can reduce disease activity in people with primary Sjögren's syndrome, an autoimmune condition that causes dry eyes, dry mouth, and fatigue. About 240 adults aged 18 to 70 with moderate-to-active disease will recei…
Phase 2 • Sponsor: Beijing InnoCare Pharma Tech Co., Ltd. • Aim: Disease control
Last updated Jul 29, 2026 00:00 UTC